Stella Pharma Balance Sheet Health
Financial Health criteria checks 6/6
Stella Pharma has a total shareholder equity of ¥3.1B and total debt of ¥853.0M, which brings its debt-to-equity ratio to 27.7%. Its total assets and total liabilities are ¥5.2B and ¥2.1B respectively.
Key information
27.7%
Debt to equity ratio
JP¥853.00m
Debt
| Interest coverage ratio | n/a |
| Cash | JP¥3.75b |
| Equity | JP¥3.08b |
| Total liabilities | JP¥2.13b |
| Total assets | JP¥5.21b |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: 4888's short term assets (¥5.0B) exceed its short term liabilities (¥219.0M).
Long Term Liabilities: 4888's short term assets (¥5.0B) exceed its long term liabilities (¥1.9B).
Debt to Equity History and Analysis
Debt Level: 4888 has more cash than its total debt.
Reducing Debt: 4888's debt to equity ratio has reduced from 135.5% to 27.7% over the past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: Whilst unprofitable 4888 has sufficient cash runway for more than 3 years if it maintains its current positive free cash flow level.
Forecast Cash Runway: 4888 is unprofitable but has sufficient cash runway for more than 3 years, due to free cash flow being positive and growing by 22.6% per year.